Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 25,567 US PATENTS IN FORCE
- 47,583 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 219,140 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
Not Available
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0180,479 | Treatment of Parkinson's Disease | Mar 08, 22 | Jun 06, 24 | Not available |
| 2024/0180,802 | USE OF NEUROSPORENE TO PROTECT THE SKIN FROM THE HARMFUL EFFECTS OF BLUE LIGHT | Oct 30, 20 | Jun 06, 24 | Not available |
| 2024/0180,807 | HAIR GROWTH AGENT | Feb 25, 22 | Jun 06, 24 | ADJUVANT HOLDINGS CO., LTD. |
| 2024/0180,816 | NOVEL COMPOSITION COMPRISING IRIS-DERIVED EXOSOME AS ACTIVE INGREDIENT | Dec 27, 23 | Jun 06, 24 | EXOCOBIO INC |
| 2024/0180,819 | LAQUINIMOD FORMULATION FOR OCULAR USE | Mar 31, 22 | Jun 06, 24 | Active Biotech AB |
| 2024/0180,830 | METHODS FOR TREATING CANCERS BY USING NANOFRAMES OF PRUSSIAN BLUE OR AN ANALOGUE THEREOF AND ITS PRODUCTION METHODS | Dec 02, 22 | Jun 06, 24 | National Cheng Kung University |
| 2024/0180,832 | COMPOUND, LIPOSOME, AND USES THEREOF | Nov 17, 23 | Jun 06, 24 | Not available |
| 2024/0180,833 | NANOVESICLES DERIVED FROM BACTERIA OF THE GENUS PARACOCCUS AND USE THEREOF | Mar 31, 22 | Jun 06, 24 | MD HEALTHCARE INC. |
| 2024/0180,835 | STERICALLY STABILIZED CARRIER COMPOSITIONS FOR TREATING A MAMMAL | Jan 03, 24 | Jun 06, 24 | Not available |
| 2024/0180,846 | Nanoformulations of Pazopanib, Compositions Comprising the Same and Methods of Treating Osteoarthritis | Jun 08, 22 | Jun 06, 24 | Not available |
| 2024/0180,847 | EXTRACELLULAR VESICLES LOADED WITH AT LEAST TWO DIFFERENT NUCLEIC ACIDS | Mar 31, 22 | Jun 06, 24 | Carmine Therapeutics Pte. Ltd. |
| 2024/0180,848 | TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION | Aug 05, 22 | Jun 06, 24 | Not available |
| 2024/0180,849 | IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY | Apr 12, 22 | Jun 06, 24 | Purdue Research Foundation |
| 2024/0180,850 | COMPOSITIONS AND METHODS FOR FABRICATING DEGRADABLE FLOCKED OBJECTS | Apr 14, 22 | Jun 06, 24 | Not available |
| 2024/0180,851 | TELOMERASE ACTIVATING COMPOUNDS FOR USE IN FERTILITY AND RELATED APPLICATIONS | Aug 25, 23 | Jun 06, 24 | Neuromagen Pharma Ltd |
| 2024/0180,853 | THERAPEUTIC METHODS USING BUPROPION HYDROBROMIDE | Jan 04, 24 | Jun 06, 24 | Not available |
| 2024/0180,854 | USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION | Feb 09, 24 | Jun 06, 24 | Not available |
| 2024/0180,855 | BIOACTIVE PRODUCTS | Apr 05, 22 | Jun 06, 24 | Not available |
| 2024/0180,857 | Livestock Feed | Mar 31, 22 | Jun 06, 24 | Sumitomo Chemical Company Limited |
| 2024/0180,858 | Treatment of Multiple Sclerosis Comprising DHODH Inhibitors | Dec 05, 23 | Jun 06, 24 | Immunic AG |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)